FIRST-IN-HUMAN PHASE I STUDY OF A DUAL MTOR KINASE AND DNA-PK INHIBITOR (CC-115) IN ADVANCED MALIGNANCY


An in-depth analysis of Convolutional Neural Network architectures with transfer learning for skin disease diagnosis

Low contrasts and visual similarity between different skin conditions make skin disease recognition a challenging task.Current techniques to detect and diagnose skin disease accurately require high-level professional expertise.Artificial intelligence paves the way Wireless Routers for developing computer vision-based applications in medical imaging

read more

Factor XI Inhibitors: A New Horizon in Anticoagulation Therapy

Abstract Anticoagulation therapy has undergone significant evolution, marked by the emergence of direct oral anticoagulants with distinct advantages.Despite these advancements, challenges persist in managing residual thrombotic and Nursing bleeding risks, particularly among vulnerable populations.The pursuit of alternative drugs has honed in on fac

read more

Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection

ABSTRACT With over 3.5 billion people at risk and approximately 390 million human infections per year, dengue virus (DENV) disease strains health care resources worldwide.Previously, we and others established models for DENV pathogenesis in mice that completely lack subunits of the receptors (Ifnar and Ifngr) for type I and type II interferon (IFN)

read more